N. Nedev

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Tomas Kron, Andrew Wirth, Benjamin Solomon, 2019, The Lancet. Oncology.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

S. Vinod, J. Ruben, L. Irving, 2019, The Lancet. Oncology.